Canadian Securities Exchange (CSE) · BIOV.CN · ISIN CA09076M2004
BioVaxys Technology Corp.
No trading activity has been reported for this listing since May 5, 2026. It may be delisted, halted or inactive.
0.0700 CAD
May 5, 2026
BioVaxys Technology Corp. (BIOV.CN) trades on the Canadian Securities Exchange and operates in the Biotechnology industry. Its market capitalisation is approximately 2.04M CAD. The company reports around 3 employees. Its ISIN is CA09076M2004. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.
Key facts
Exchange
Canadian Securities Exchange (CSE)
ISIN
CA09076M2004
Sector
Healthcare
Industry
Biotechnology
Country
CA
Market cap
2.04M CAD
Employees
3
Previous close
0.06 CAD
Day range
0.07 – 0.07
52-week range
0.03 – 0.40
Volume
13.47K
50-day average
0.08 CAD
200-day average
0.20 CAD
Asset type
Equity
About BioVaxys Technology Corp.
BioVaxys Technology Corp. is a clinical-stage biotechnology company specializing in the development of vaccine platforms designed to combat both viral infections and cancer. The company's pipeline includes BVX-0320, a single-strain vaccine for SARS-CoV-2, and BVX-0918A, an experimental haptenized tumor cell vaccine targeting ovarian cancer. Additionally, BioVaxys offers CoviDTH, an immunodiagnostic tool to detect immune system activity in SARS-CoV-2-exposed patients. Further initiatives encompass Papilocare, aimed at HPV-dependent cervical lesions, along with BVX-0918C for cervical cancer, the HPV viral vaccine BVX-0204, and BVX-0121, a multivalent SARS-CoV-2 vaccine. BioVaxys has established strategic collaborations, such as a bioproduction agreement with WuXi Biologics Limited to manufacture SARS-CoV-2 s-proteins crucial for BVX-0320 and CoviDTH. It also holds a research partnership with The Ohio State University, Wexner School of Medicine, focusing on BVX-0320, and has engaged Bioanalytical Systems, Inc. for preclinical toxicology evaluations of its CoviDTH immunodiagnostic. The company is headquartered in Vancouver, Canada.
Company websiteFrequently asked
- What is the BIOV.CN share price today?
- This page shows the latest available BioVaxys Technology Corp. (BIOV.CN) price with its change against the prior close. Values are delayed or previous-close, not real-time.
- Where is BioVaxys Technology Corp. listed?
- BioVaxys Technology Corp. trades on the Canadian Securities Exchange under the symbol BIOV.CN, ISIN CA09076M2004.
- How large is BioVaxys Technology Corp.?
- Its market capitalisation is approximately 2.04M CAD, based on the latest available price and share count from our data provider.
+
+
+
All BioVaxys Technology Corp. data comes from exchange and provider feeds for the Canadian Securities Exchange and is published for information, not as investment advice.
Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.